SEC Form 4 · accession 0001209191-17-059168
HTG MOLECULAR DIAGNOSTICS, INC · HTGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shaun D McMeans
Officer — VP, Finance & Admin. & CFO
Period of report
Nov 1, 2017
Accepted (ET)
Nov 3, 2017 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001169987
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 1, 2017 | S | 945 | $2.26 | D | 43,248 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted on September 15, 2017.